Bright Minds Biosciences Inc (DRUG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 35 | -2,059 | -1,482 | -1,674 | -1,237 |
| Depreciation Amortization | 15 | 54 | 40 | 27 | 13 |
| Other Working Capital | -85 | 29 | -39 | 74 | 426 |
| Other Operating Activity | -1,033 | 616 | 468 | 367 | 194 |
| Operating Cash Flow | $-1,067 | $-1,360 | $-1,014 | $-1,206 | $-604 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,514 | 0 | N/A | N/A | N/A |
| Other Financing Activity | 34,654 | 596 | 610 | 635 | 645 |
| Financing Cash Flow | $37,168 | $596 | $610 | $635 | $645 |
| Exchange Rate Effect | 1,164 | 9 | -4 | -33 | -31 |
| Beginning Cash Position | 4,085 | 4,959 | 4,931 | 5,002 | 4,956 |
| End Cash Position | 41,350 | 4,204 | 4,523 | 4,398 | 4,966 |
| Net Cash Flow | $37,265 | $-755 | $-408 | $-605 | $10 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,067 | -1,360 | -1,014 | -1,206 | -604 |
| Free Cash Flow | -1,067 | -1,360 | -1,014 | -1,206 | -604 |